Trademarkia Logo

Canada

C$
CELL THERAPY LOGO
REGISTERED

on 14 Jan 2020

Last Applicant/ Owned by

CELL THERAPY LIMITED

The Maynard Centre, Block CD1, Room 1:62Forest Farm Industrial Estate, Longwood DriveCardiff CF14 7YT

GB

Serial Number

1815656 filed on 22nd Dec 2016

Registration Number

TMA1069475 registered on 14th Jan 2020

Registration expiry Date

14th Jan 2030

Correspondent Address

JENSEN IP

234 - 38 Auriga DriveOttawa,

ONTARIO

CA

K2E8A5

CELL THERAPY LOGO

Trademark usage description

pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts namely treatment for cardiovascular, cardiopulmonary, ge Read More

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 3

Sectors of circles or ellipses (except 26.2.7)Secteurs de cercle ou d'ellipse (excepté 26.2.7)

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 1 . 4

Two circles, two ellipses, one inside the otherDeux cercles, deux ellipses, l'un dans l'autre

26 . 1 . 7

Circles containing one or more ellipsesCercles contenant une ou plusieurs ellipses

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts namely treatment for cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory and gastrointestinal diseases; pharmaceutical preparations for the treatment of viral diseases, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, mumps, shingles, chicken pox, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of disorders of the endocrine system, namely diabetes, thyroid disorders, metabolic syndrome and osteoporosis; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely dermatitis, skin pigmentation diseases, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders, namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely autoimmune diseases and disorders, immunologic deficiency syndromes; pharmaceutical and veterinary pharmaceutical preparations for use in promoting cellular, tissue, and organ regeneration; pharmaceutical preparations for use in facilitating regeneration of damaged and diseased skin, tissue and organs; cellular medicines, namely, stem cells, tissue engineered cells and gene edited cells for medical and veterinary purposes; food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; preparations for destroying vermin; fungicides, herbicides;


Classification kind code

11

Mark Details


Serial Number

1815656

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 20th Jun 2019
Agent Changed
Submitted for opposition 67
on 20th Jun 2019
Agent Name Changed
Submitted for opposition 15
on 7th Jun 2019
Correspondence Created
Submitted for opposition 15
on 13th Nov 2018
Correspondence Created
Submitted for opposition 15
on 13th Jun 2018
Correspondence Created
Submitted for opposition 22
on 21st Nov 2017
Search Recorded
Submitted for opposition 20
on 21st Nov 2017
Examiner's First Report
Submitted for opposition 31
on 29th Dec 2016
Formalized
Submitted for opposition 1
on 28th Dec 2016
Created
Submitted for opposition 30
on 22nd Dec 2016
Filed